Effect of biofeedback and deep oscillation on Raynaud’s phenomenon secondary to systemic sclerosis: results of a controlled prospective randomized clinical trial-Reference-Cited by-同舟云学术

Effect of biofeedback and deep oscillation on Raynaud’s phenomenon secondary to systemic sclerosis: results of a controlled prospective randomized clinical trial

Published:2011-04-08 Issue:5 Volume:32 Page:1469-1473
ISSN:0172-8172
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Sporbeck Birte,Mathiske-Schmidt Kirsten,Jahr Silke,Huscher Dörte,Becker Mike,Riemekasten Gabriela,Taufmann Ines,Burmester Gerd-Rüdiger,Pögel Stephanie,Reisshauer Anett

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s00296-011-1882-2.pdf

Reference9 articles.

1. LeRoy EC (1996) Systemic sclerosis. A vascular perspective. Rheum Dis Clin North Am 22(4):675–694

2. Sunderkotter C, Riemekasten G (2006) Pathophysiology and clinical consequences of Raynaud’s phenomenon related to systemic sclerosis. Rheumatology (Oxford) 45(Suppl 3):iii33–iii35

3. Riemekasten G, Sunderkotter C (2006) Vasoactive therapies in systemic sclerosis. Rheumatology (Oxford) 45(Suppl 3):iii49–iii51

4. Foerster J, Fleischanderl S, Wittstock S, Storch A, Meffert H, Riemekasten G, Worm M (2005) Infrared-mediated hyperthermia is effective in the treatment of scleroderma-associated Raynaud’s phenomenon. J Invest Dermatol 125(6):1313–1316

5. Jahr S, Schoppe B, Reisshauer A (2008) Effect of treatment with low-intensity and extremely low-frequency electrostatic fields (Deep Oscillation) on breast tissue and pain in patients with secondary breast lymphoedema. J Rehabil Med 40(8):645–650

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interdisziplinäre Therapieansätze der systemischen Sklerose;rheuma plus;2024-08-05

2. Drug Therapy;Raynaud’s Phenomenon;2024

3. Non-drug Approaches to Treating Raynaud’s Phenomenon;Raynaud’s Phenomenon;2024

4. Clinical Outcome Measures in Raynaud’s Phenomenon;Raynaud’s Phenomenon;2024

5. Systematic literature review informing the EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis;RMD Open;2023-08